Page 16 - Aplus Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Digital comics startup Madefire is shutting down R.I.P. Madefire, a startup that recruited high-profile artists to reinvent comics for new formats and platforms. An announcement on the Madefire website states the company entered into “an assignment of benefit for creditors” (explained as “a state-level insolvency proceeding similar to bankruptcy”) earlier this month, which was then reported this morning in The Beat. As a result, no new books will be published, users will not be able to purchase any additional books and they’re also encouraged to download all their purchased content ...

Share Data-focused health startup Innovaccer has officially landed unicorn status after raising a whopping $105 million in Series D funding. Tiger Global Capital led the round with participation from B Capital Group and Steadview Capital. The round brings the company’s total funding to $225 million with a $1.3 billion valuation. Its Series C funding round was announced a year ago and raised $70 million. The company employs AI and data analytics to help unify healthcare data for easier healthcare management. The product is able to organize doctor’s notes and give insights and analysis ...

China Digest: Muliang eyes $40m Nasdaq IPO; neoX Biotech, Resproly raise fresh capital Source: Markus Winkler/Unsplash February 2, 2021 Chinese fertiliser producer Muliang is seeking to raise $40 million in a Nasdaq IPO, while biotech startup neoX Biotech and inhalation therapy developer Resproly have closed new funding rounds to expand operations. Fertiliser producer Muliang to raise $40m in Nasdaq IPO Chinese fertiliser producer Muliang Viagoo Technology (MLVG) is seeking to raise $40 million on the Nasdaq this week by offering 10 million shares at a price of $4 apiece. At the proposed deal...

© 2021 China Money Network Limited. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.